Background: Previous studies have identified a discrepancy between patient perception of asthma control and real-world symptoms; despite several hypotheses, the reasons remain unclear.
Introduction
Asthma is one of the most common chronic conditions, affecting approximately 30 million people in Europe [1] [2] [3] and over 5 million patients in the UK. 4 Asthma represents a significant health burden, costing the UK National Health Service around £1 billion per year. 5, 6 Poor asthma control is associated with an impaired healthrelated quality of life, lost productivity, emergency hospital admissions (costing £642-2,245 per admission in the UK), and an increased risk of exacerbations and death. 5, [7] [8] [9] [10] [11] The British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN) guideline on the management of asthma 12 indicates that treatment should be based on disease severity. Other influential guidelines, such as those from the Global Initiative for Asthma (GINA), 1 emphasise control. Asthma control encompasses the patient's recent clinical state (symptoms, night-time awakening, reliever inhaler use, lung function), ability to carry out usual daily activities, and exacerbation risk. 13 The BTS/SIGN guidelines base asthma control on the healthcare professional (HCP)'s clinical judgement and the patient's recent symptoms, which can be assessed using tools such as the Asthma Control Questionnaire (ACQ), the Royal College of Physicians (RCP) '3 Questions', or the Asthma Control Test (ACT). 12 Based on current definitions of asthma control, real-world asthma control remains poor. 14, 15 In a recent European study, approximately half of all UK patients had asthma that was not well
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PRIMARY CARE RESPIRATORY JOURNAL www.thepcrj.org controlled. 14 Other studies have also consistently reported a tendency for both HCPs and patients to overestimate the level of asthma control achieved. 5, 7, [16] [17] [18] [19] [20] [21] Indeed, many patients consider their asthma to be controlled despite experiencing severe symptoms. 18 Several reasons have been suggested for the discrepancy between real-world asthma control and patient or HCP perceptions. 5, 7, [16] [17] [18] [19] [20] [21] Possible factors relating to patients include poor medication adherence and low expectations of symptom control; 17, 20, 22 for HCPs, influential factors include a lack of awareness or implementation of guidelines, undertreatment with inhaled corticosteroids, and failure to recognise frequent reliever inhaler use as an indication of poor control. 19, 23 Communication difficulties between patients and HCPs also affect control, and studies have identified discrepancies between patients' expectations and their experiences with HCPs. 17, 20 In one study almost 20% of patients had not discussed their asthma with an HCP. 20 Indeed, improved education and more time to develop a partnership between HCPs and patients are recognised as being central to asthma management. 24 This survey of over 1,000 patients in the UK explored levels of asthma symptoms and their impact on patients' lives, individuals' experiences of asthma and its management, and current educational needs. Our findings provide a timely assessment of whether asthma control and management have changed in recent years.
Methods

Study design
This quantitative online survey was designed to assess patients' attitudes to, and experiences of, asthma and its management in a real-world setting. A market research questionnaire was developed to collect data directly reported by respondents. In line with the 2012 Legal and Ethical Guidelines for Healthcare Market Research (British Healthcare Business Intelligence Association), 25 research ethics committee approval was not required. The survey was carried out in accordance with the Codes of Conduct of the Market Research Society, the European Pharmaceutical Marketing Research Association, the Association of the British Pharmaceutical Industry, and the Data Protection Act (UK, 1998).
Questionnaire development
The authors, in collaboration with Insight Research Group (London, UK), developed the questionnaire through an iterative process of consultations with asthma experts, including HCPs and patient organisations. Questionnaire wording and length and the suitability of pre-codes were assessed in telephone interviews with two patients.
For questions relating to day-time or night-time symptoms, steroid use, Accident and Emergency department (A&E) visits and discussions of symptoms with HCPs, respondents were asked to recall their experiences over the previous two years. This period was chosen to allow accurate memory recall and to capture a representative average of symptoms, including rare events.
Study population
The online survey was conducted in November 2011 by YouGov. An e-mail was sent to 5,563 adults (aged >18 years) of the UK public who had identified themselves as having asthma when they enrolled in the YouGov panel and who declared an intention to complete online surveys. In the current survey, respondents were asked to confirm that they had been diagnosed with asthma and were currently receiving treatment; only respondents who affirmed were invited to complete the survey.
Data analysis
Questionnaire responses were collated by YouGov and provided to Insight Research Group for analysis in line with the survey protocol. Descriptive statistics (mean, median, and standard deviation) were calculated.
Results
Respondent population
Overall, 5,563 individuals who had previously stated that they had asthma represented the pool of potentially eligible participants. In all, 1,083 respondents (19%) confirmed that they had been diagnosed with asthma and were currently receiving asthma medications, and completed the survey (Table 1) ; this response rate is consistent with that typically observed by YouGov for similar surveys.
Respondent-reported real-world asthma symptoms
Overall, 65% of respondents (n=702) had experienced frequent ('sometimes', 'often' or 'every day') day-time asthma symptoms and 37% (n=398) had experienced frequent night-time symptoms in the past 2 years (Figure 1 ). The most common day-time symptoms were wheezing, coughing, and breathlessness (Table 2) . Moreover, 12% of respondents (n=135) had visited A&E and 25% (n=274) had used oral steroids, both owing to asthma, in the previous two years. Of the 881 respondents prescribed a reliever inhaler, 41% used it Values are given as % (n). regularly (at least once a day; Figure 2 ). When asked about the impact of asthma on their life, respondents most commonly selected: being unable to go out in cold weather (27%, n=293), participating in sport or hobbies as much as they would like (24%, n=264), and being unable to go out in hot or humid weather as much as they would like (17%, n=179).
Respondents' understanding and perception of asthma control
Respondents' understanding of the term 'asthma control' varied markedly. The majority thought that 'good asthma control' meant being able to do all the daily activities that they want to (70%, n=763), breathing without problems (68%, n=736), and using their reliever inhaler less (59%, n=642). Approximately half of respondents considered 'good asthma control' to mean not having trouble sleeping (49%, n=532) and being able to exercise or take part in sport (47%, n=508). 'Having none of the normal asthma symptoms' (as interpreted by respondents) was selected as a definition for 'good asthma control' by only 40% of respondents (n=436), and 33% (n=362) chose 'having no symptoms'.
The majority of respondents thought that their asthma was controlled even if they had 'frequent' symptoms or regularly used their reliever inhaler (Table 3) . Overall, 79% of respondents (n=859) Values are given as % (n). *Base: excludes those not answering the question (n=41) and those responding that they don't know (n varied). PRIMARY CARE RESPIRATORY JOURNAL www.thepcrj.org described their asthma control as 'very good' or 'good'. However, 28% (n=241) of these respondents used their reliever inhaler at least once a day, 8% (n=71) used it at least three times a day, and 58% (n=500) had frequent day-time symptoms. Similarly, although 91% of respondents (n=986) were satisfied with their asthma control, 31% (n=305) of these used their reliever inhaler at least once a day. Of the 854 respondents who had ever had uncontrolled asthma, 76% were confident in managing their symptoms after a loss of control. Only 19% were either 'not very confident' (16%) or 'not at all confident' (3%) in managing uncontrolled asthma; 5% of respondents selected 'don't know'.
The majority of respondents (59%, n=640) considered that it was not possible to improve their asthma control. This attitude was more prevalent among those with infrequent day-time symptoms than those with frequent day-time symptoms (72%, n=274) vs. 52%, n=366). Respondents who thought that improvements in control were possible (n=443) agreed on several suggestions to achieve this (Table 4) . 'Frequently' included the answers 'often (a few times a week)', 'sometimes (a few times a month)' and 'every day'. 'Rarely' was qualified as 'rarely (a few times a year)'.
Total answers for reliever use: n=881 (includes don't know: n=2). Total answers for emergency department visits: n=1,083 (includes don't know: n=12). 
Contact with HCPs involved in asthma management
In all, 91% of respondents (n=983) had asthma consultations in general practitioner (GP) surgeries, with a practice nurse (69%) and/or a GP (60%). Discussions about asthma symptoms with GPs occurred less than once a year (33% of respondents), yearly (31%), or every six months (20%), while nurses were most commonly seen yearly (50%) or every six months (25%); only 15% of respondents saw a practice nurse less than once a year. The higher frequency of consultations with nurses may reflect the fact that nurses are often responsible for routine asthma reviews. The majority of respondents (78%, n=841) had been invited to an asthma review. However, 18% (n=200) of respondents stated they had never been invited (4% could not recall). Of those who had been invited for a review, 81% (n=684) stated they had always attended and 17% (n=147) had not always attended (1% could not recall). Overall, 32% (n/N=347/1,083) of respondents had therefore either never been invited to a review or had not always attended. Notably, 15% of respondents with frequent day-time symptoms and 14% of respondents with frequent night-time symptoms had not always attended reviews. For those respondents who did not always accept invitations (n=147), the reasons selected included: the perception that asthma was well controlled (40%); difficulty arranging a convenient appointment (29%); no time for an appointment (23%); the belief that their HCP was unable to do anything to improve their asthma (23%); previous reviews had not been helpful (18%). Of the 854 respondents who had experienced symptoms in the past two years, 85% had discussed their asthma with their HCP; these discussions most commonly covered medication review, inhaler technique, and symptom management (Table 5) .
Overall, 28% (n=300) of respondents had discussed a personal asthma action plan (PAAP) with their HCP. Only 12% of all respondents were currently using a PAAP ( Figure 3) ; 81% of these were involved in its development and 42% consulted it at least once a month. Most considered their PAAP to be 'very useful' (59%, n=76) or 'fairly useful' (31%, n=40). The most common reasons given by respondents for not discussing a PAAP with their HCP were unawareness that the plans were available (56%, n=346) and the
Outcome of discussions in those with symptoms who
Reasons why those with symptoms did not discuss them with their discussed them with their healthcare professional (n=729) healthcare professional (n=126) PRIMARY CARE RESPIRATORY JOURNAL www.thepcrj.org belief that their asthma was well controlled (32%, n=201) or not serious enough (31%, n=193). Most respondents rated the relationship with their HCP as 'very good' (45%, n=482) or 'good' (32%, n=342). Respondents' feedback on how to improve the relationship included having a plan to improve asthma control (16%, n=171), working together with the HCP (15%, n=165), and having more time for the consultation (11%, n=120). However, 55% (n=592) thought that nothing could improve the relationship.
Responsibility for asthma control
Overall, 70% of respondents (n=758) felt that they rather than their HCP had the 'main responsibility' for ensuring that their asthma was controlled; this proportion was similarly high in patients with frequent symptoms (Figure 4 ). In general, respondents accepted their symptoms and did not expect additional assistance from their HCP ( Figure 5 ).
Discussion
Main findings
This comprehensive survey of patients with asthma in the UK shows that a significant discrepancy remains between patients' perceptions of asthma control and the symptoms that they experience. Although the majority of respondents believed that their asthma was controlled, many experienced frequent symptoms affecting their daily lives. Most respondents felt that they had a good relationship with their HCP; however, many patients thought that they had the main responsibility for managing their asthma and did not expect further help from their HCP. Moreover, while many respondents had been invited to a review, one in six of those who had been invited had not always attended. Only 12% of respondents said they currently used a PAAP; this was marginally higher than in a study of UK patients from 2007 (when it was reported as 8%), indicating little improvement in recent years. 26 
Strengths and limitations of the study
This was a survey of over 1,000 asthma patients drawn from a large panel of the UK population. In contrast to clinical trials where up to 98% of patients may not meet the strict inclusion/exclusion criteria, 27 this survey reflects the experiences of real-world patients, providing a basis for further research. As with all studies, this survey has limitations. Almost half of all respondents were aged 55 years or older; all data were directly reported by the respondents, who had previously stated that they had asthma. The screening question asked participants to confirm both the diagnosis and treatment of asthma to ensure that their answers related solely to this disease, hence the diagnosis was not independently confirmed. However, it is possible that some patients may have had chronic obstructive pulmonary disease (COPD), or COPD with asthma. In addition, some questions reflected the RCP '3 Questions', but the timescale (previous two years) was longer than that specified by the BTS/SIGN guidelines (the preceding month). 12 In this survey, the longer timeframe was used to permit the capture of both a representative average of symptoms and rarer events.
Interpretation of findings in relation to previously published work
Our results provide a timely update on asthma in the UK, and highlight that little progress has been made in recent years in improving patients' knowledge and understanding of control. 15, 18, 28 In a survey from 2004, 91% of patients with asthma from the UK regarded their asthma as under control even though two-thirds had symptoms at least two or three times a week. 28 These findings are broadly similar to results from a recent European survey in which 91% of respondents perceived their asthma as controlled, even though 53% of these patients had awoken due to asthma in the week before the survey and 43% had required the use of oral steroids due to asthma in the previous year. 29 This discrepancy was consistently observed for the overall study population and for those within each country. 30 Implications for future research, policy and practice
The present study confirms that many patients with asthma have an impaired health-related quality of life and low expectations of improvement. Over 80% of respondents accepted that they would get symptoms and that asthma would have an impact on their life. Nonetheless, almost 60% thought that their asthma control could not be improved; there is clearly a need for more education and initiatives to raise patients' expectations.
Respondents' low expectations of achieving asthma control and the discrepancy between perceived control and symptoms may reflect misunderstandings regarding the term 'asthma control'. Some patients may consider good asthma crisis management -such as knowing what to do when they become symptomatic or have an attack -as being in control of their asthma. The asthma community may therefore want to reconsider the language used to define asthma control; as well as focusing on current symptoms, it may also be appropriate to consider the risk of asthma attacks. Patients can then assess this risk and make appropriate decisions.
Regular structured reviews can help improve asthma control. 31 Reviews are one of the indicators in the Quality and Outcomes Framework (QOF) and National Institute for Health and Care Excellence standards used to assess the quality of primary care organisations and practices in the UK. 32 Practices receive additional payments for achieving specified asthma management targets. This survey shows that asthma reviews often included an assessment of symptoms and inhaler technique, and discussions of a PAAP, in line with QOF requirements. However, contrary to BTS/SIGN and GINA recommendations, 1, 12 almost one in five respondents stated that they had never been invited to a review. Importantly, almost one in six of those respondents with frequent day-time or night-time symptoms had not always attended reviews. Indeed, many respondents saw an HCP about their asthma less than once a year; some patients may not attend reviews because they do not consider themselves 'sick' and want to maintain a healthy self-image. Also, this survey was conducted in a population that uses the internet, so it may be worthwhile to explore alternative ways of providing asthma reviews and information to patients. Indeed, these findings raise the issue of how to motivate patients to participate in reviews -especially those who may benefit from them the most. An alternative to face-to-face reviews could be telephone or online consultations. Telephone consultations are a cost-effective way to increase review rates, improve patients' confidence in managing their asthma, 33 and target clinical care to those patients at high risk. 34 By contrast, the evidence on the effectiveness of telecare is less clear. 35 Asthma guidelines, including those from BTS/SIGN and GINA, recommend PAAPs for adults with persistent asthma. 1, 12 PAAPs improve adherence and asthma control 36, 37 and reduce emergency consultations. 37 This survey confirmed the utility of PAAPs, with 90% of those using a plan describing it as useful; it was therefore disappointing that only 28% of respondents had discussed a PAAP with their HCP, and only 12% were currently using one. This shows little improvement from the 2004 UK survey, which found that 80% of patients had never been provided with a PAAP. 28 Other studies have also highlighted the limited use of PAAPs. [38] [39] [40] The recommended use of PAAPs reflects an increased emphasis on patients managing their own asthma, and a recent study suggests that many patients prefer an active or collaborative role. 41, 42 The low take-up of PAAPs and reviews in our survey population suggests that the sense of responsibility for asthma control may have shifted; only a small minority of respondents thought that their HCPs had the main responsibility for asthma care, and the majority did not expect additional assistance. In the past, HCPs may have been too prescriptive (preventing patients from taking a more active role), but the balance of responsibility may now have shifted too far towards the patient and away from the HCP. A more collaborative partnership focusing on patient-centred care would probably be optimal; this should include regular reviews and PAAPs to meet patients' need for information and support their self-management in the first few months after diagnosis. [43] [44] [45] In clinical practice, it is important to assess asthma control regularly using a validated tool such as the ACQ, RCP '3 Questions', or ACT, 1, 12 and to communicate the relevance and implications of these results to the patient. This will help patients understand how their current level of asthma control relates to their risk of exacerbations and what steps they can take to improve control.
Conclusions
This large survey highlights a continuing discrepancy between patient perception of asthma control and real-world symptoms. Most patients feel satisfied with their asthma treatment and have low expectations of improving their symptom control. Respondents generally feel that they have the main responsibility for their asthma management, despite having a good relationship with their HCPs. Our findings suggest a need to improve patients' understanding of the causes of poor asthma control and effective management of symptoms. It may be time for a radical rethink about how asthma is managed in primary care. Patients' needs and behaviours are continually changing, and personalised care (including regular asthma reviews and PAAPs) is more important than ever. Efforts should focus on understanding and removing the barriers to better asthma control, changing patients' beliefs and behaviours, and the importance of sharing responsibility for asthma management through an effective partnership between patients and HCPs. Achieving these aims will require continued education for both parties.
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